- Home
- AHR vs APLS Comparison
AHR vs APLS Comparison
Compare AHR & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AHR
- APLS
- Stock Information
- Founded
- AHR 2013
- APLS 2009
- Country
- AHR United States
- APLS United States
- Employees
- AHR N/A
- APLS N/A
- Industry
- AHR
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- AHR
- APLS Health Care
- Exchange
- AHR NYSE
- APLS Nasdaq
- Market Cap
- AHR 4.5B
- APLS 4.4B
- IPO Year
- AHR 2024
- APLS 2017
- Fundamental
- Price
- AHR $28.25
- APLS $35.29
- Analyst Decision
- AHR Buy
- APLS Buy
- Analyst Count
- AHR 8
- APLS 19
- Target Price
- AHR $25.25
- APLS $49.89
- AVG Volume (30 Days)
- AHR 2.2M
- APLS 3.6M
- Earning Date
- AHR 02-12-2025
- APLS 11-05-2024
- Dividend Yield
- AHR 3.52%
- APLS N/A
- EPS Growth
- AHR N/A
- APLS N/A
- EPS
- AHR N/A
- APLS N/A
- Revenue
- AHR $2,005,322,000.00
- APLS $715,216,000.00
- Revenue This Year
- AHR N/A
- APLS $95.53
- Revenue Next Year
- AHR $6.99
- APLS $12.94
- P/E Ratio
- AHR N/A
- APLS N/A
- Revenue Growth
- AHR 9.88
- APLS 162.10
- 52 Week Low
- AHR $12.63
- APLS $24.34
- 52 Week High
- AHR $29.99
- APLS $73.80
- Technical
- Relative Strength Index (RSI)
- AHR 58.28
- APLS 61.76
- Support Level
- AHR $27.85
- APLS $31.76
- Resistance Level
- AHR $28.91
- APLS $34.98
- Average True Range (ATR)
- AHR 0.72
- APLS 1.53
- MACD
- AHR -0.14
- APLS -0.04
- Stochastic Oscillator
- AHR 54.39
- APLS 76.77
About AHR AMERICAN HEALTHCARE REIT INC
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing primarily on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. They have four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of revenue through Integrated Senior Health Campuses segment.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.